Search research articles
Contact Us
Filters
Showing results (61-70 of 81) with videos related to
Page
of 9
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation
|
October 23, 2024
Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies
Wei Z Yeh, Anneke Van Der Walt, Olga G Skibina, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
September 16, 2021
Retinal Optical Coherence Tomography in Neuromyelitis Optica
Frederike Cosima Oertel, Svenja Specovius, Hanna G Zimmermann, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 18, 2025
First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis
Simona Toscano, Tim Spelman, Serkan Ozakbas, et al.
Journal of Neurology
|
June 27, 2024
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic
Anoushka P Lal, Yi Chao Foong, Paul G Sanfilippo, et al.
Journal of Neurology
|
September 28, 2023
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies
Ying Li, Alice Saul, Bruce Taylor, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 6, 2023
Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial
Ibrahima Diouf, Charles B Malpas, Sifat Sharmin, et al.
BMJ Open
|
October 30, 2020
Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO)
Svenja Specovius, Hanna G Zimmermann, Frederike Cosima Oertel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 10, 2019
Risk of secondary progressive multiple sclerosis: A longitudinal study
Adam Fambiatos, Vilija Jokubaitis, Dana Horakova, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 29, 2021
Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders
Angelo Lu, Hanna G Zimmermann, Svenja Specovius, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 17, 2023
Disability accrual in primary and secondary progressive multiple sclerosis
Sam Harding-Forrester, Izanne Roos, Ai-Lan Nguyen, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 81) with videos related to
Sort By:
Page
of 9
Neurology(R) Neuroimmunology & Neuroinflammation
|
October 23, 2024
Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies
Wei Z Yeh, Anneke Van Der Walt, Olga G Skibina, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
September 16, 2021
Retinal Optical Coherence Tomography in Neuromyelitis Optica
Frederike Cosima Oertel, Svenja Specovius, Hanna G Zimmermann, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 18, 2025
First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis
Simona Toscano, Tim Spelman, Serkan Ozakbas, et al.
Journal of Neurology
|
June 27, 2024
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic
Anoushka P Lal, Yi Chao Foong, Paul G Sanfilippo, et al.
Journal of Neurology
|
September 28, 2023
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies
Ying Li, Alice Saul, Bruce Taylor, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 6, 2023
Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial
Ibrahima Diouf, Charles B Malpas, Sifat Sharmin, et al.
BMJ Open
|
October 30, 2020
Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO)
Svenja Specovius, Hanna G Zimmermann, Frederike Cosima Oertel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 10, 2019
Risk of secondary progressive multiple sclerosis: A longitudinal study
Adam Fambiatos, Vilija Jokubaitis, Dana Horakova, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 29, 2021
Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders
Angelo Lu, Hanna G Zimmermann, Svenja Specovius, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 17, 2023
Disability accrual in primary and secondary progressive multiple sclerosis
Sam Harding-Forrester, Izanne Roos, Ai-Lan Nguyen, et al.
Page
of 9